Three Treatments for Chronic Venous Insufficiency: Escin, Hydroxyethylrutoside, and Daflon
Identifieur interne : 00A426 ( Main/Exploration ); précédent : 00A425; suivant : 00A427Three Treatments for Chronic Venous Insufficiency: Escin, Hydroxyethylrutoside, and Daflon
Auteurs : Robert W. Frick ; Robert W. FrickSource :
- Angiology [ 0003-3197 ] ; 2000-03.
Abstract
Escin, hydroxyethylrutoside (HR), and Daflon have been shown to be safe and effective for the treatment of chronic venous insufficiency (CVI). They seem to work differently than compression therapy, suggesting that they would usefully augment this therapy. All three phlebotonics attenuate the drop in adenosine triphosphate in venous endothelial cells during hypoxia. This attenuates (1) the inflammation response, (2) the attraction of neutrophils, (3) damage to the veins, and (4) the release of growth factors. These factors otherwise would perpetuate venous insufficiency and contribute to varicose veins. Additional independent effects that would be useful for the treatment of CVI are that they reduce permeability and fragility; HR, Daflon, and perhaps escin increase venous tone; escin inhibits hyaluronidase; Daflon and probably HR are attracted to the veins. With regard to similarity, no differences in effect have been established among these phlebotonics.
Url:
DOI: 10.1177/000331970005100303
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 005758
- to stream Istex, to step Curation: 005758
- to stream Istex, to step Checkpoint: 002F45
- to stream Main, to step Merge: 00A963
- to stream Main, to step Curation: 00A426
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Three Treatments for Chronic Venous Insufficiency: Escin, Hydroxyethylrutoside, and Daflon</title><author wicri:is="90%"><name sortKey="Frick, Robert W" sort="Frick, Robert W" uniqKey="Frick R" first="Robert W." last="Frick">Robert W. Frick</name></author><author wicri:is="90%"><name sortKey="Frick, Robert W" sort="Frick, Robert W" uniqKey="Frick R" first="Robert W." last="Frick">Robert W. Frick</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BA3746F4CEEC090F2B7EE44EF76CFE3030976496</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1177/000331970005100303</idno><idno type="url">https://api.istex.fr/document/BA3746F4CEEC090F2B7EE44EF76CFE3030976496/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">005758</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">005758</idno><idno type="wicri:Area/Istex/Curation">005758</idno><idno type="wicri:Area/Istex/Checkpoint">002F45</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002F45</idno><idno type="wicri:doubleKey">0003-3197:2000:Frick R:three:treatments:for</idno><idno type="wicri:Area/Main/Merge">00A963</idno><idno type="wicri:Area/Main/Curation">00A426</idno><idno type="wicri:Area/Main/Exploration">00A426</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Three Treatments for Chronic Venous Insufficiency: Escin, Hydroxyethylrutoside, and Daflon</title><author wicri:is="90%"><name sortKey="Frick, Robert W" sort="Frick, Robert W" uniqKey="Frick R" first="Robert W." last="Frick">Robert W. Frick</name></author><author wicri:is="90%"><name sortKey="Frick, Robert W" sort="Frick, Robert W" uniqKey="Frick R" first="Robert W." last="Frick">Robert W. Frick</name><affiliation><wicri:noCountry code="subField">11790</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Angiology</title><idno type="ISSN">0003-3197</idno><idno type="eISSN"></idno><imprint><publisher>Sage Publications</publisher><pubPlace>Sage CA: Thousand Oaks, CA</pubPlace><date type="published" when="2000-03">2000-03</date><biblScope unit="volume">51</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="197">197</biblScope><biblScope unit="page" to="205">205</biblScope></imprint><idno type="ISSN">0003-3197</idno></series><idno type="istex">BA3746F4CEEC090F2B7EE44EF76CFE3030976496</idno><idno type="DOI">10.1177/000331970005100303</idno><idno type="ArticleID">10.1177_000331970005100303</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0003-3197</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Escin, hydroxyethylrutoside (HR), and Daflon have been shown to be safe and effective for the treatment of chronic venous insufficiency (CVI). They seem to work differently than compression therapy, suggesting that they would usefully augment this therapy. All three phlebotonics attenuate the drop in adenosine triphosphate in venous endothelial cells during hypoxia. This attenuates (1) the inflammation response, (2) the attraction of neutrophils, (3) damage to the veins, and (4) the release of growth factors. These factors otherwise would perpetuate venous insufficiency and contribute to varicose veins. Additional independent effects that would be useful for the treatment of CVI are that they reduce permeability and fragility; HR, Daflon, and perhaps escin increase venous tone; escin inhibits hyaluronidase; Daflon and probably HR are attracted to the veins. With regard to similarity, no differences in effect have been established among these phlebotonics.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Frick, Robert W" sort="Frick, Robert W" uniqKey="Frick R" first="Robert W." last="Frick">Robert W. Frick</name><name sortKey="Frick, Robert W" sort="Frick, Robert W" uniqKey="Frick R" first="Robert W." last="Frick">Robert W. Frick</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00A426 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00A426 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:BA3746F4CEEC090F2B7EE44EF76CFE3030976496
|texte= Three Treatments for Chronic Venous Insufficiency: Escin, Hydroxyethylrutoside, and Daflon
}}
| This area was generated with Dilib version V0.6.31. |  |